glp 1 and intracranial hypertension Scientists discover common obesity diabetes drug reduces rise in brain pressure Glucagon-like peptide-1 medicines in neurological

BPC-157: The Tissue Protector Body Protection Compound-157 is derived from a naturally occurring protein found in gastric juice

conversion of acetanilide to paracetamol, and phenylbutazone to oxyphenbutazone

No degeneration or inflammation was observed.In the CARB group, follicular atresia, cytoplasmic vacuolization, nuclear pyknosis, and degenerative changes in granulosa cells were evident (yellow star)

This brief duration of action is why pharmaceutical companies developed longer-acting GLP-1 receptor agonists for therapeutic use

Insoluble fibre adds bulk to stools and promotes regular bowel movements, which becomes especially relevant given that constipation is a common or very common side effect of GLP-1 drugs, depending on the specific product and dose